Author

Efim Pozharskiy

Observed names: Efim D. Pozharskii, Efim Pozharsky

Institution: Moscow Multidisciplinary Clinical Center "Kommunarka"

Observed institution: Moscow Multidisciplinary Clinical Center "Kommunarka"

ORCID: 0009-0006-4422-848X

Observed ORCID: 0009-0006-4422-848X

OpenAlex ID: A5092612296

Venetoclax after Progression on Ibrutinib: Results of a Russian Multicenter Study

2023 · Maria Kislova, Olga Kalashnikova, et al. · Blood · 2

Pb2030: Hyperchromic Anemia as the First Manifestation of Myeloproliferative Disease

2023 · Sergey Lepkov, Natalia Gavrilina, et al. · HemaSphere · 1

Intermediate results of efficacy and safety of combined treatment with brentuximab vedotin and bendamustine for refractory and relapsed forms of peripheral T-cell lymphoma: A retrospective study

2024 · Efim D. Pozharskii, Natalia G. Chernova, et al. · Journal of Modern Oncology

P1096: Treatment of Hepatitis C-associated Marginal Zone Lymphoma(hcv+lmz) With Direct-acting Antiviral Drugs (daas)

2023 · Sergey Lepkov, Gayne Tumyan, et al. · HemaSphere

Works count: 4

Citation count: 3

H-index: 1

I10-index: